PJSIMP
BIIB icon

P.J. Schmidt Investment Management (PJS)’s Biogen BIIB Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-745
Closed -$217K – 137
2015
Q3 		$217K Sell
745
-1,288
-63% -$425K 0.09% 128
2015
Q2 		$821K Buy
2,033
+821
+68% +$329K 0.32% 87
2015
Q1 		$512K Hold
1,212
– – 0.2% 105
2014
Q4 		$411K Buy
+1,212
New +$392K 0.16% 114

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s BIIB Position: Q4 2015 in Review

P.J. Schmidt Investment Management (PJS) sold out of Biogen (BIIB) in Q4 2015, closing a stake of 745 shares — an estimated $217K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in BIIB in Q4 2014 and held it in 4 quarters. The position peaked at $821K in Q2 2015. 969 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • P.J. Schmidt Investment Management (PJS) reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • P.J. Schmidt Investment Management (PJS) sold 745 Biogen shares in Q4 2015, an estimated $217K.
  • P.J. Schmidt Investment Management (PJS) first reported a position in Biogen in Q4 2014 and held it in 4 quarters.
  • P.J. Schmidt Investment Management (PJS)'s Biogen position peaked at $821K in Q2 2015.
  • 969 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q4 2015, filed 29 Jan 2016.